Why Partner
Position Your Company at the Forefront of Gene Editing
With 2025 being yet another momenteous year for genome editing therapeutics, attendees greatly benefited from connecting with the experts actively advancing the next wave of safe and durable therapies at the 6th Genome Editing Therapeutics Summit.
This much-loved forum provided you with an unmatched platform to showcase your company’s services, expertise, solutions and brand to the growing number of biopharma, continuing to incorporate gene editing into their development.
This year senior leaders were eager to partner with organizations with reliable solutions and robust capabilities to support:
CDMOs
CRISPR Construct Providers & Reagents
Vector Providers
CROs
Animal Model Providers
CRISPR-Engineered Cell Lines
Genome Sequencing
Genomic Analysis
Reach out today to discuss how we can support you in establishing strong relationships with this unique group through one of our trusted partnership positions in 2026
Proud to Partner With
“The Genome Editing Therapeutics Summit was outstanding. There was opportunity to network with all participants and because of the smaller size of the conference, we were able to have free flowing conversations”
Radhika Ganeshan, Product Manager, Aldevron, 2025 Sponsor
Meet with Leading Genome Editing Experts
